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Abstract 
Background: Type II diabetes is known as one of the most important, prevalent, and expensive diseases of 
mankind. Late diagnosis and subsequent delayed initiation of treatment or surveillance of patients create a 
variety of problems for affected individuals. This has raised increasing concerns for public health authorities 
throughout the world. In the current study, we aimed to find a new approach for early identification of high-risk 
individuals at initial months of their life. This allows us to take preventive measures as early as possible. 
Materials and Methods: In our study, 102 infants - from one to six months - were selected and placed in two 
case and control groups. The case group contained 52 babies with at least one of their parents identified as a 
type II diabetic patient. The control group comprised 50 babies with no family history of type II diabetes in 
paternal and maternal first-degree relatives. Afterwards, the expression level of insulin gene was analyzed in 
white blood cells of both groups. Information related to infants - referred to outpatient and inpatient wards of 
three main pediatric hospitals placed in Tehran - and their parents were collected through questionnaires within 
a two-year period. The study inclusion criteria for infants were confirmed type II diabetes in at least one of their 
parents, the absence of any metabolic disorder, and the absence of any disturbing vital signs. After drawing 2 
ml of babies’ peripheral blood, total RNA of white blood cells (WBC) was extracted, and used for cDNA 
synthesis. Real-Time PCR was then applied to quantitatively evaluate the expression levels of insulin gene. The 
results of Real-Time PCR were statistically analyzed by non-parametric tests of Mann-Whitney and Kruskal-
Wallis. 
Results: The expression of insulin gene was observed in white blood cells of all samples. However, there 
was a significant difference in expression levels between case and control groups (p<0.05). There was a 
statistically significant difference in mean levels of gene expression among babies with diabetic mother, and 
healthy groups (RQ=0.5, P-value=0.002), but this value wasn’t significant for babies with diabetic father 
(RQ=0.78, P>0.05). 
Conclusion: Numerous genes contribute to the development of diabetes and novel disease-causing genes are 
increasingly being discovered. Identification of disease-prone individuals through examining merely one 
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underlying gene is complicated and challenging. Interestingly, all of these abnormally functioning genes finally 
manifest themselves in the altered expression levels of insulin gene. The expression status of insulin gene in 
WBCs could be suggested as a useful approach for identification of individuals at high risk for developing 
diabetes. This paves the way for taking appropriate measures at infancy period in order to prevent the disease as 
well as inhibit its various side effects in the following years of patient’s life. 
Keywords: insulin, gene expression, diabetes screening, type II diabetes prevention  
 
*Corresponding Author: Vahid Reza Yassaee, MD, PhD;  1- Genomic Research Center, Taleghani Hospital, Aarabi St., Yaman Ave., 
Evin, Velenjak, Shahid Beheshti University of Medical Sciences, Tehran-1966645643, Iran 
2- Dept. of Medical Genetic, Faculty of Medicine, Shahid Beheshti University of Medical Sciences,Tehran-1966645643, Iran. Tel: (+98) 21 
22439959. Fax: (+98) 21 22439961. Email: s.reza.mazhari@gmail.com 
 
Please cite this article as: Mazhari SR, Mirfakhraie R, Asadi M, Alipour Olyaei N, Kheiri HR, Moslemi E, et al. Comparison of the 






Type II diabetes has proven to be as one of the most 
important, prevalent, and money-consuming chronic 
diseases for human (1, 2). Late diagnosis and 
subsequent deferred initiation of treatment or 
surveillance of patients have provoked growing 
concerns for public health professionals (3). World 
health Organization (WHO) defines diabetes as a 
disorder in which the body cannot produce enough 
insulin or cannot appropriately use the insulin 
produced (4). In this condition, the capacity of cells 
to fully metabolize sugars is lowered which leads 
ultimately to the increase of blood sugar. In addition 
to sugars, extensive irregularities also occur in the 
metabolism of proteins and lipids (5). Therefore, 
diabetes in its strict definition is a metabolic 
syndrome. Diabetes is a significant, widespread, and 
high-cost disease in contemporary societies and 
urban development, modernization, and the change 
of life-style have highlighted its importance. The age 
of disease development has been reduced 
dramatically and this trend is growing in an alarming 
manner (6).  
Type II diabetes is mostly associated with changes in 
the three-dimensional structure as well as function of 
certain proteins such as insulin receptor on the cell 
surface, and many agents known as molecular 
intermediates which function intracellularly after 
receptor activation. Malfunction of all of these 
proteins results from alterations in their encoding 
genes (7). Thus far, more than 100 genetic loci 
associated with diabetes have been identified (8). 
However, the list of novel genes linked to diabetes is 
continually expanding. Although type II diabetes has a 
genetic origin and some of its harmful effects appear 
from the very initial years of life, the first paraclinical 
signs, including increased FBS (Fast Blood Sugar) or 
abnormal glucose tolerance tests are usually seen 
during the fourth decade of life and thereafter (9).  
Screening assays for early identification of diabetic 
patients mainly focus on measurement of FBS, CPG 
(causal plasma glucose), glucose tolerance test, and 
hemoglobin A1c.  The major goal of these assays is to 
initiate therapy as early as possible and prevent side 
effects of the disease. These side effects include 
nephropathy, retinopathy, neuropathy, and a variety of 
other secondary disorders which if remain untreated, 
will lead to diverse complications for the patient. It is 
known that damages begin to appear long before 
emergence of hyperglycemia even from the early days 
of life and severe harms to the pancreas gradually 
result in the decrease of insulin production (10, 11).  
Apart from considering a number of risk factors, there 
is not any systematic and rigorous approach for 
identification of patients before the above-mentioned 
symptoms occur. Screening programs for early 
diagnosis of the disease are performed after the age of 
30 and are based on detecting alterations in the levels 
of blood sugar, analyzing glucose tolerance tests, etc. 
Although public health authorities, following 
guidelines recommended by WHO, suggest life-style 
change as the major strategy to inhibit chronic 
disorders such as diabetes, adhering to these guidelines 
is also influenced by patient phenotype and non-
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specific risk factors. On the other hand, the complex 
genetic pattern of diabetes - as seen in many 
polygenic disorders - makes it difficult to exactly 
assess the risk of the disease.  
The involvement of over 100 genes associated with 
diabetes (8), with a diverse range of possible 
alterations such as deletion, point mutation, and 
different polymorphisms not only causes difficulty 
for risk assessment, but also makes the procedure 
uneconomical and money-consuming. However, 
taking one important characteristic of diabetes into 
account may present a solution to this problem. In 
type II diabetes, minor and major changes in disease- 
related genes introduce alterations into the structure 
and function of proteins which in turn lead to the 
decline of glucose uptake from blood by cells. The 
feedback induced by increased blood glucose on beta 
cells of the islets of Langerhans, irrespective of its 
underlying type of genetic alteration, elevates insulin 
production (12). This raises the question whether it is 
possible to analyze the expression level of insulin in 
the pancreas and use this information in order to 
evaluate one of the primary molecular reactions of 
the body during the first days of a baby’s life.  The 
lack of accessibility of pancreas and problems of 
sampling through biopsy for screening purposes 
make it impossible to analyze the insulin gene 
expression in the target pancreatic tissue. Therefore, 
another question is raised: could the expression 
analysis of insulin in an easy-to-sample tissue such as 
white blood cells lead to satisfactory results? The 
current study aimed to address these questions. 
Answer to these questions provides an appropriate 
means for identification of diabetes-prone individuals 
at birth. Furthermore, as this information determines 
the chance of disease development, it facilitates 
programming for prevention of diabetes itself and not 
only treatment of its symptoms. 
Methods 
Demographic and biologic data on patients: 102 
infants, from one to six months, were chosen for the 
study. These babies had been referred to outpatient, 
inpatient, and laboratory wards of three pediatric 
hospitals located in Tehran, including Mofid 
Children’s Hospital, Children’s Medical Center, and 
Vali-e-Asr Hospital. All selected babies fulfilled the 
inclusion criteria (Table 1).  
The  infants were selected based on face to face 
(directed) interviews with their parents and primary 
laboratory examinations. The same questionnaire was 
allocated to all selected individuals and based on 
information received. They were divided into case and 
control groups. Babies with no family history of 
diabetes (in first-degree and second-degree relatives) 
were placed in control group and babies with diabetes 
in at least one of their parents were placed in case 
group. Out of 1674 infants, 110 individuals were 
chosen for complementary examinations in order to be 
checked for inclusion in the case group. 52 of 110 
babies met the inclusion criteria and the rest were 
excluded from the study. 1564 infants had non-
diabetic parents or grand-parents among which 50 
individuals were selected for the control group. The 
nonexistence of diabetes in voluntary parents was 
confirmed by using FBS (Fasting blood sugar) test. In 
contrast, only information received through interviews 
or taking family history was used for maternal and 
paternal grandparents and other second-degree relative 
variables related to selected samples are shown in 
Table 1.  
After informed consent was obtained from parents, 1-2 
ml of peripheral blood was drawn from babies and 
poured into special EDTA tubes. Maintaining cold 
chain, the tubes were transferred to the main storage 
place within less than 3 hours.  
RNA extraction: RNA extraction was performed 
immediately after receiving the samples using standard 
protocol. 100μl of each sample was poured into 
separate sterile microtubes and then 500μl of ice cold 
RNX-PLUS was added to the solution, vortexed for 10 
seconds, and incubated at room temperature for 5 
minutes. 200μl of chloroform was added to the 
microtubes and vortexed for 15 seconds. The 
microtubes were placed on ice for 5 minutes in order 
to be prepared for centrifugation. After centrifugation 
at 12000 rpm for 15 minutes, the supernatant was 
transferred to a new microtube and incubated with 
isopropanol. The microtubes were again centrifuged at 
12000 rpm for 15 minutes. The supernatant was 
removed and the precipitate was incubated with 
1000μl of 75% ethanol. The suspension was 
centrifuged at 7500 rpm for 8 minutes and the 
supernatant was discarded. The pellet was kept at 
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room temperature to dry. Finally, 50μl of DEPC-
treated water was added to the pellet. The extracted 
RNA was stored at -20C before being used for 
cDNA synthesis.  
cDNA synthesis: cDNA was synthesized by using 
cDNA synthesis kit (Vivantis company) 10μl of 
RNA, 1μl of 10 mM dNTP, and  1 μl of random 
hexamer were mixed together. The mixture was 
incubated at 65C for 5 minutes. Afterwards, 2μl of 
10X MMULV  and 0.5 ml of MMULV enzyme were 
added and the final volume was adjusted to 20μl by 
adding deionized water. The microtubes were 
incubated at 42C for 1 hour.  
Primer design: Specific primers were designed to 
amplify sequences encoding insulin and GAPDH 
genes. To inhibit the amplification of genomic DNA, 
primers were designed in a manner that could bind to 
and amplify exon-exon junctions. Both primers in a 
primer set were capable of annealing to neighboring 
exons. As a result, PCR reaction could favor the 
amplification of short fragment derived form 
template cDNA, not genomic DNA or primers could 
bind to exon-exon junction and only amplified cDNA. 
Table 2 shows characteristics of the primers. The 
optimum annealing temperature of all primers was set 
at 60C.  
The quality and quantity of RNA were examined using 
UV spectrophotometry and agarose gel 
electrophoresis.  
Real-Time PCR: qPCR reactions were performed in 
96-well plates with a final volume of 20μl for each 
well. PCR master mix solutions for target and 
reference genes were prepared separately. Each 
reaction contained 18μl of master mix and 2μl of 
synthesized cDNA. Analyses of amplification and 
melt curves were performed based on Applied 
Biosystems 7500 using SYBR Premix Ex Taq Kit 
(Perfect Real Time) (Takara, Japan).  
The quality of PCR products was analyzed by using 
1.5% agarose gel electrophoresis. To evaluate the 
expression of insulin gene in infants with a family 
history of diabetes and control babies, the expression 
analysis of insulin gene in both groups was performed 
through RNA extraction, cDNA synthesis, and Real-




Total number of primarily examined  individuals 1674 
Number of individuals with ambiguous medical history* 542* 
Number of individuals with disturbed vital signs ** 430** 
Number of individuals with other important background diseases*** 181*** 
Number of individuals not exclusively fed with mother’s milk 937 
Number of individuals with problems in laboratory procedures and tests 124 
Total number of individuals excluded from the study **** 1572**** 
Total number of individuals included into the study 102 
Number of case individuals 52 
Number of control individuals 50 
*Considering the necessity of obtaining information on grandparents, parents of this category of babies did not provide adequate 
information on grandparents.  
 ** Many of those who were referred to Mofid Children’s Hospital, Children’s Medical Center, and Vali-e-Asr Hospital (particularly 
inpatient cases) had at least one disturbed vital sign.    
*** Considering the fact that samples were selected from those who were referred to medical centers for diagnostic and therapeutic 
purposes, a considerable number of them had important background health-related problems.  
**** Due to the presence of some common study exclusion factors, total number of excluded individuals due to different factors 
mentioned in the table is higher than the true number of those who were excluded from the study. 
 
 
Table 2: Sequence of the primers used in Real-Time PCR reaction. 
PCR Product Size  Primer Sequence Primer Name 
124 bp 5' ATGGAGAAGGCTGGGGCT 3' GAPDH F 
5' ATCTTGAGGCTGTTGTCATACTTCTC 3' GAPDH R 
148 bp 5' TTCTTCTACACACCCAAGACCC 3' INSULIN F 
5' TACAGCATTGTTCCACAATGC 3' INSULIN R 
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Time PCR. After the reaction was completed, data 
were extracted from the thermal cycler as CT and 
gene expression was quantified by using  ∆∆CT 
method. The graphs were then drawn by GraphPad 
software. 
Results 
To evaluate the specificity of primers, be assured of 
amplifying specific fragments, and examine the lack 
of generation of nonspecific PCR products, melt 
curves were drawn separately for insulin and 
GAPDH genes by Real-Time PCR machine. The 
graphs confirmed the specific annealing of the 
primers to the sequence of insulin gene and its 
subsequent amplification.  
The identity of PCR product was confirmed by 
performing electrophoresis on 1.5% agarose gel  The 
agarose gel electrophoresis of PCR product revealed 
the amplification of a single band size matched the 
molecular weight of the amplified insulin-coding 
sequence.  
Expression analysis of insulin gene: The results of 
Real-Time PCR exhibited the expression of insulin 
gene in WBCs of both case and control groups. Table 
4 indicates the results of insulin gene (INS) 
expression analysis in both case and control 
categories.   
The comparative expression analysis of GAPDH and 
insulin genes was performed using ∆∆CT method and 
RQ calculation. Detailed analysis of the results of gene 
expression in case group highlighted the fact that 
despite overall reduced expression of insulin in case 
versus the control group, some case individuals 
indicated increased levels of insulin expression. This 
enhanced expression is found in 9 of 52 individuals in 
case group (17.3%). But, as previously mentioned, a 
significant number of infants with diabetic father or 
mother showed decreased levels of insulin expression 
compared with control group (82.7%). According to 
Kolmogorov-smirnov statistical test, gene expression 
Table 3: Program used for Real-Time PCR reaction. 
Program Step 
Initial denaturation: 95 ˚C, 10 seconds, 1 cycle 1 
Denaturation: 95 ˚C, 15 seconds. 45 cycles 2 
Extension: 60 ˚C, 60 seconds 3 
 
 Table 4: Evaluation of the expression levels of insulin gene in case and control groups. 
102 Total number of individuals/nursing babies selected for the study 
52 Number of case individuals 
50 Number of control individuals 
20 Number of case individuals with diabetic father 
32 Number of case individuals with diabetic mother 
0.63 
Mean expression levels of insulin in case individuals compared with control 
individuals 
0.80 
Mean expression levels of insulin in case individuals with diabetic father 
compared with control individuals 
0.52 
Mean expression levels of insulin in case individuals with diabetic mother 





Graph 1. Comparison of mean RQ between case and control 
group. 
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data have a normal distribution (P-value=0.05). The 
expression level of insulin in diseased group was 
0.63 fold relative to  healthy one. Thus, the 
parametric T-test was used for comparison of both 
groups. Analysis based on this parametric test 
suggested a significant difference between case and 
control groups (P-value =0.017) (Graph 1). 
 Furthermore, independent sample T-test revealed 
that there is a statistically significant difference in 
mean levels of gene expression among babies with 
diabetic mother, and healthy groups (RQ=0.5, P-
value=0.002), but this value wasn’t significant for 
babies with diabetic father(RQ=0.78, P-value>0.05) 
(Graph 2).  Compare means between babies with 
diabetic mother and babies with diabetic father 
showed 0.64 fold expression in first group relative 
second one but this difference was statistically 
insignificant. 
Discussion 
Decreased binding of insulin to its cognate receptor 
on the cell surface and abnormalities induced by 
structural changes of intracellular signal-transducing 
proteins, leading to reduce of the glucose take up by 
cells from the blood (13). This increases the blood 
glucose level and subsequently laboratory signs of 
diabetes appear. In type II diabetes with abnormal 
structures of cellular proteins, compensatory elevated 
production of insulin by pancreas controls the blood 
glucose level before hypoglycemia occur (12). Thus, 
it is expected the expression of insulin gene in the 
pancreatic beta cells is enhanced before disease onset 
or even a long time after emergence of paraclinical 
signs. This could be used as a molecular method for 
early diagnosis of the disease when paraclinical signs 
have not yet been observed. More ever, biopsy 
samples cannot be taken from the pancreatic tissue for 
screening purposes. As a result, it is importance to find 
and use the patient cells which are available and easy-
to-sample, express insulin gene, and similar to beta 
cells of the islets of langerhans are influenced by 
changes resulting from decreased uptake of glucose by 
cells.  
Previous studies have demonstrated that WBCs 
express over 80% of identified genes (14). This 
suggests that white blood cells represent potential to 
be used as candidate cells for early diagnosis of 
diabetes. At the very beginning of life, these cells may 
provide some clues on type II diabetes. It was 
previously believed that insulin gene is exclusively 
expressed in the pancreatic beta cells (15). However, it 
has now become evidant that WBCs not only express 
insulin gene, but also show alterations in the 
expression levels of insulin during starvation (14). It 
was initially thought WBCs, like beta cells of the islets 
of langerhans, indicate higher expression levels of 
insulin in insulin-resistant individuals than normal 
ones. In normal condition, the pancreatic beta cells are 
responsive to elevated levels of blood glucose and 
release their own insulin reserves. Due to the short 
half-life of insulin, the release of insulin reserves and 
its consumption in the body necessitate further insulin 
production. Specific feedback mechanisms contribute 
to the increase of the insulin mRNA synthesis (15).  
When insulin receptor or proteins related to glucose 
uptake pathway are structurally impaired, glucose 
uptake from the blood is decelerated, blood glucose 
levels remain high, and therefore insulin secretion 
continues. Production of excess insulin proceeds until 
reaching an appropriate concentration. The result of 
this compensatory production of insulin is reflected by 
decrease of blood glucose. This process, initiated from 
the very beginning of life, continues as long as 
pancreas maintains its capacity for producing excess 
insulin. It was previously postulated feedbacks which 
impact the pancreatic beta cells also affect white blood 
cells and lead to the increased expression of insulin. 
 
 
Graph 2. Comparison of mean RQ among case individuals with 
diabetic father, case individuals with diabetic mother, and 
control individuals. 
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Our findings indicate that the expression of insulin 
gene in infants with diabetic parents is significantly 
reduced versus babies with no family history of 
diabetes. In other words, the function of white blood 
cells presents a strike contrast to the function of beta 
cells. This difference could be explained by different 
hypotheses.  
An interesting study by Choong Chin Liew et al. 
(2005) indicated that starvation and feeding can 
change the expression of insulin gene. They 
demonstrated that starvation and feeding lead to the 
increase and decrease of the insulin gene expression, 
respectively. These results support the observations 
of our study. One of the other aspects of our study is 
that alterations observed in the expression levels of 
insulin gene is in accordance with statistical findings 
obtained from epidemiological reports on diabetes. 
According to epidemiological findings, if one of the 
parents has type II diabetes their children will have 
approximately 15% chance for developing the 
disease (16). Assuming the correlation of decreased 
expression of insulin gene in white blood cells and 
diabetes, our results indicated the reduced insulin 
expression in 82.7% of babies with diabetic parents. 
Seven percent probability of disease development 
does not contradict the presence of at least a number 
of tens of impaired genes associated with type II 
diabetes in healthy children.  
Development of diabetes and appearance of 
paraclinical signs arise from minor and major 
changes in disease-related genes. In this context, it is 
possible that total consequence of these changes in 
healthy children of a diabetic father or mother will 
not be high enough to create the disease. Therefore, it 
is not surprising that we saw different levels of 
decreased insulin gene expression in white blood 
cells derived from babies. In our study, 82.7% of 
babies with one diabetic parent showed a significant 
decline in the expression levels of insulin. Our results 
exhibited the expression levels of insulin gene vary 
from 1/10
6
 to 98.5%.  
Further investigations as cohort studies with a larger 
sample size and future monitoring of babies will be 
helpful to fulfill the complementary goals of our 
study. Early identification of babies at risk of 
developing type II diabetes from birth, improvement 
of nutritional condition, and weight management 
programs play important roles in maintaining the 
functional capacity of the pancreas. If the pancreas is 
freed from pressures triggered by producing higher 
amounts of insulin, its longevity increases and 
therefore the beginning of diabetes symptoms is 
delayed. This delay reduces diabetes- mediated side 
effects in terms of both types of pathological signs and 
severity. 
Conclusion 
As a result, it seems that babies with higher decreased 
levels of insulin are more likely to develop the disease. 
In this study, we tried to use a homogenized condition 
for all babies. However, it cannot be ignored that 
uncontrollable condition could disturb homogeneity 
and introduce bias. To achieve a homogenized 
condition, all infants in the study were selected to be 
between one to six months. In this time period, babies 
exclusively fed with mother’s milk are selected and 
thus error induced by variations in the nutritional 
condition of babies is dramatically lowered. Also, all 
babies were included into the study at least one-month 
after their birth. Elapse of one month from birth makes 
it possible to identify many important chronic diseases 
such as metabolic disorders. Babies with these types of 
diseases were excluded from the study. On the other 
hand, the one-month period of time counteracts the 
interfering effects of insulin which is produced in the 
mother’s body and transferred to the baby’s body via 
umbilical cord. 
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